vix.ing · top · new · best · stats · spec

Identification of α-galactosylceramide as an endogenous mammalian antigen for iNKT cells

2024/11/20 by Yuki Hosono, Noriyuki Tomiyasu, Hayato Kasai +10 · 1 voice
Immunology and Microbiology · #Immune Cell Function and Interaction #T-cell and B-cell Immunology #Immunotherapy and Immune Responses

paper · pdf · doi:10.1084/jem.20240728

openalex publication_date 2024/11/20 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31

Abstract

Invariant natural killer T (iNKT) cells are unconventional T cells recognizing lipid antigens in a CD1d-restricted manner. Among these lipid antigens, α-galactosylceramide (α-GalCer), which was originally identified in marine sponges, is the most potent antigen. Although the presence of α-anomeric hexosylceramide and microbiota-derived branched α-GalCer is reported, antigenic α-GalCer has not been identified in mammals. Here, we developed a high-resolution separation and detection system, supercritical fluid chromatography tandem mass spectrometry (SFC/MS/MS), that can discriminate hexosylceramide diastereomers (α-GalCer, α-GlcCer, β-GalCer, or β-GlcCer). The B16 melanoma tumor cell line does not activate iNKT cells; however, ectopic expression of CD1d was sufficient to activate iNKT cells without adding antigens. B16 melanoma was unlikely to generate iNKT cell antigens; instead, antigen activity was detected in cell culture serum. Activity-based purification and SFC/MS/MS identified dihydrosphingosine-based saturated α-GalCer as an antigenic component in serum, bile, and lymphoid tissues. These results show the first evidence for the presence of potent antigenic α-GalCer in mammals.

Citations

Discussions

Related